Carregando empresa
Just reported
From Teva Pharmaceutical Industries's results release of 3 de novembro de 2026; its quarterly report has since been filed.
Actual
US$ 4,4B
-1,9% y/y
+6,1% q/q
Guided
—
No guide given
Actual
US$ 0,20
-46% y/y
Guided
—
No guide given
EPS, adjusted: US$ 0,86
Actual
US$ 714M
-19% y/y
Guided
—
No guide given
Operating income, adjusted: US$ 1,39B
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Teva Pharmaceutical Industries is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
TAKTakeda Pharmaceutical Company LimitedUS$ 34,4BA
NBIXNeurocrine Biosciences, Inc.US$ 16,9BA+
ELANElanco Animal Health IncorporatedUS$ 13,4BA
KNSAKiniksa Pharmaceuticals International, plcUS$ 8,2BA+
LQDALiquidia CorporationUS$ 5,2BARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 de out. de 2026CBGraded C, now B
MCKMckesson Corporation4 de nov. de 2026BAGraded B, now A
CVSCVS Health Corp4 de nov. de 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 de nov. de 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 de out. de 2026CAGraded C, now ADemonstrações financeiras completas →
Construído a partir dos próprios documentos de Teva Pharmaceutical Industries Limited entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.
Grade C
A faixa sob o preço mostra a nota em cada data, calculada só com os documentos já públicos naquele momento.
Mostrando 2 de 41 trimestres do histórico de notas de Teva Pharmaceutical Industries Limited. Os outros 39 vão até novembro de 2016.
